IBUPROFEN AND FAMOTIDINE

Camber Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Jul 19, 2023
Approval ID: 7dc158a2-fdfa-4a5f-8c28-0ce5650991db
Products: 1 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use IBUPROFEN and FAMOTIDINE TABLETS safely and effectively. See full prescribing information for IBUPROFEN and FAMOTIDINE TABLETS. IBUPROFEN and FAMOTIDINE tablets, for oral use Initial U.S. Approval: 2011

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.